NF
PFE icon

NTB Financial’s Pfizer PFE Stock Holding History

NTB Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$595K Buy
11,342
+146
+1% +$7.44K 0.48% 64
2022
Q1 		$580K Sell
11,196
-91
-0.8% -$4.72K 0.41% 70
2021
Q4 		$667K Buy
+11,287
New +$559K 0.47% 61

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NTB Financial's PFE Position: Q2 2022 in Review

NTB Financial increased its Pfizer (PFE) stake by 1.3% in Q2 2022, buying an estimated $7.44K and bringing the position to 11,342 shares worth $595K. The position accounts for 0.48% of the portfolio, ranked #64.

NTB Financial first reported a position in PFE in Q4 2021 and has held it in 3 quarters since. The position peaked at $667K in Q4 2021. 3,160 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • NTB Financial held 11,342 shares of Pfizer worth $595K as of Q2 2022.
  • NTB Financial bought 146 Pfizer shares in Q2 2022, an estimated $7.44K.
  • Pfizer made up 0.48% of NTB Financial's portfolio in Q2 2022, its #64 holding.
  • NTB Financial first reported a position in Pfizer in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Pfizer position peaked at $667K in Q4 2021.
  • 3,160 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.